AAPL353.43-2.85 (-0.80%) ▼|ABBV296.48+1.45 (+0.49%) ▲|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|AAPL353.43-2.85 (-0.80%) ▼|ABBV296.48+1.45 (+0.49%) ▲|ABT108.39-0.13 (-0.12%) ▼|ACN251.40+0.91 (+0.36%) ▲|ADBE249.07+5.99 (+2.46%) ▲|AMAT352.20-18.30 (-4.94%) ▼|AMD505.08-28.98 (-5.43%) ▼|AMGN466.92+1.25 (+0.27%) ▲|AMT191.03-0.62 (-0.32%) ▼|AMZN258.50-8.16 (-3.06%) ▼|AVGO331.81-15.20 (-4.38%) ▼|AXP318.55-2.05 (-0.64%) ▼|BA166.14-5.36 (-3.13%) ▼|BAC50.06-0.96 (-1.88%) ▼|BKNG156.95-2.63 (-1.65%) ▼|BLK1,199.56-23.36 (-1.91%) ▼|BMY63.33-0.10 (-0.16%) ▼|BNY151.93-1.48 (-0.96%) ▼|BRK-B593.13+0.19 (+0.03%) ▲|C121.28-2.73 (-2.20%) ▼|CAT574.35-25.85 (-4.31%) ▼|CL101.64+1.97 (+1.98%) ▲|CMCSA25.62+0.46 (+1.83%) ▲|COF192.77-1.51 (-0.78%) ▼|COP140.18-1.17 (-0.83%) ▼|COST1,111.47+5.26 (+0.48%) ▲|CRM216.73-1.11 (-0.51%) ▼|CSCO94.69-0.95 (-0.99%) ▼|CVS88.27-1.08 (-1.21%) ▼|CVX217.25-2.64 (-1.20%) ▼|DE660.11-13.43 (-1.99%) ▼|DHR231.93-1.10 (-0.47%) ▼|DIS118.29-0.68 (-0.57%) ▼|DUK130.38+1.22 (+0.94%) ▲|EMR161.01-5.37 (-3.23%) ▼|FDX326.67+2.53 (+0.78%) ▲|GD359.62-3.84 (-1.06%) ▼|GE326.86-4.95 (-1.49%) ▼|GEV762.96-40.17 (-5.00%) ▼|GILD169.22+1.14 (+0.68%) ▲|GM83.82-2.18 (-2.53%) ▼|GOOG283.67-8.85 (-3.03%) ▼|GOOGL286.53-9.24 (-3.12%) ▼|GS889.70-26.86 (-2.93%) ▼|HD348.19-0.50 (-0.14%) ▼|HON220.06-2.41 (-1.08%) ▼|IBM244.32-2.81 (-1.14%) ▼|INTC55.26-4.41 (-7.38%) ▼|INTU348.99+7.29 (+2.13%) ▲|ISRG441.79-1.80 (-0.41%) ▼|JNJ284.93-0.82 (-0.29%) ▼|JPM338.92-7.27 (-2.10%) ▼|KO99.46+0.21 (+0.21%) ▲|LIN526.32+0.26 (+0.05%) ▲|LLY1,443.31-0.19 (-0.01%) ▼|LMT582.92-13.12 (-2.20%) ▼|LOW226.69-1.05 (-0.46%) ▼|LRCX210.88-15.04 (-6.66%) ▼|MA664.41+3.22 (+0.49%) ▲|MCD276.35+4.38 (+1.61%) ▲|MDLZ68.06+0.52 (+0.76%) ▲|MDT103.30+0.44 (+0.42%) ▲|META624.89-16.80 (-2.62%) ▼|MMM183.26-0.40 (-0.22%) ▼|MO78.81+0.17 (+0.22%) ▲|MRK146.37-1.39 (-0.94%) ▼|MS184.21-6.44 (-3.38%) ▼|MSFT521.11-2.77 (-0.53%) ▼|MU722.39-55.92 (-7.19%) ▼|NEE85.54+0.42 (+0.49%) ▲|NFLX60.87-1.28 (-2.06%) ▼|NKE37.82-0.17 (-0.45%) ▼|NOW100.53-1.72 (-1.69%) ▼|NVDA155.25-7.60 (-4.67%) ▼|ORCL118.96-6.39 (-5.10%) ▼|PEP147.69+2.25 (+1.55%) ▲|PFE28.95+0.06 (+0.19%) ▲|PG173.13+3.33 (+1.96%) ▲|PLTR161.10-6.89 (-4.10%) ▼|PM196.43-2.53 (-1.27%) ▼|QCOM170.86-1.61 (-0.93%) ▼|RTX195.70-2.88 (-1.45%) ▼|SBUX108.04+1.60 (+1.50%) ▲|SCHW93.34+0.36 (+0.38%) ▲|SO94.08+1.25 (+1.35%) ▲|SPG231.12-1.85 (-0.79%) ▼|T22.31+0.13 (+0.56%) ▲|TMO695.19-5.03 (-0.72%) ▼|TMUS171.88+1.93 (+1.14%) ▲|TSLA378.61-11.62 (-2.98%) ▼|TXN295.91-7.70 (-2.53%) ▼|UBER69.67-0.02 (-0.03%) ▼|UNH410.10+2.64 (+0.65%) ▲|UNP304.43+1.99 (+0.66%) ▲|UPS111.29+0.53 (+0.48%) ▲|USB60.44-0.55 (-0.90%) ▼|V427.39+1.63 (+0.38%) ▲|VZ46.43+0.07 (+0.15%) ▲|WFC84.38-1.68 (-1.95%) ▼|WMT128.25+0.16 (+0.12%) ▲|XOM167.38-2.14 (-1.26%) ▼|
13 C
New York
Monday, November 16, 2026

Tag: time

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

LONDON, July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection...

Lowe’s Foundation Investment in Solving Skilled Trades Labor Shortage Grows to $43 Million

Third cohort of community and technical colleges grant recipients will launch and expand new training programs for thousands of aspiring tradespeople MOORESVILLE, N.C., July 18,...

Canadian Investment Regulatory Organization Trading Halt – PRIZ

VANCOUVER, BC, July 18, 2025 /CNW/ - The following issues have been halted by CIRO: Company: Prismo Metals Inc. CSE Symbol: PRIZ All Issues: Oui Reason: Pending News Halt...

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced its intention to voluntarily delist from the Nasdaq Capital Market (“Nasdaq”) and to deregister its common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations under Section 15(d) of the Exchange Act.

Gibbons Pools, Long Island Pool Innovator, Celebrates 50 Years

Marking a half-century milestone in 2025, the family-owned company, led by its third generation, has expanded from residential pools to include wellness amenities and...

“Deeply human, empathetic service backed by elite technical performance”: One Step GPS Wins 2025 Grand Stevie® Award

SAN FERNANDO, Calif., July 18, 2025 /PRNewswire/ -- One Step GPS is excited to announce it has been awarded the 2025 Grand Stevie Award...

Encompass Health announces plans to build a 40-bed inpatient rehabilitation hospital in Cleveland, Tennessee

BIRMINGHAM, Ala. and CLEVELAND, Tenn., July 18, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a freestanding, 40-bed inpatient rehabilitation...

Transaction in Own Shares

Transaction in Own Shares

Monster Energy’s UNLEASHED Podcast Welcomes BMX Athletes Jamie Bestwick and Andy Buckworth on Special Live Episode at X Games Salt Lake City 2025

Episode 505 of the Sports and Pop Culture Podcast Recorded Live at X Games Salt Lake City 2025 SALT LAKE CITY, July 18, 2025 /PRNewswire/...

Disclosure of notification received from Alychlo

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET

Fortnite Got Milk – With Dairy MAX

Dairy MAX's "Diner Tycoon" Is Out Now, Aiming To Put Dairy Back On The Map For Gen Z GRAND PRAIRIE, Texas, July 18, 2025 /PRNewswire/ --...

The American College of Surgeons Advances New Clinical Data Strategy to Improve Surgical Care for Patients

Collaboration with Epic is first phase of a multiyear project that will include multiple technology partners CHICAGO, July 18, 2025 /PRNewswire/ -- Long recognized as...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTime